Key result
Pre-treatment with the Cx43 hemichannel blocker Gap19 prevented isoproterenol-induced abnormal electrocardiographic behavior and reduced arrhythmogenic events in S3A mice.
Why the study?
The mechanisms by which remodeled Cx43 promotes spontaneous ventricular arrhythmias remain debated, and whether opening of remodeled Cx43 hemichannels alters cardiac excitability independent of underlying cardiomyopathy-associated cellular dysfunction is unknown.
Does opening of remodeled Cx43 hemichannels mediate cardiac stress-induced arrhythmogenicity?
Does opening of remodeled Cx43 hemichannels mediate cardiac stress-induced arrhythmogenicity?
Absolute Event Rate: 26.3% vs 130.4%
Opening of remodeled Cx43 hemichannels is sufficient to mediate cardiac stress-induced arrhythmogenicity, highlighting a potential therapeutic target for preventing arrhythmias.
Remodeled Cx43 hemichannels suffice for stress-induced arrhythmias in mice lacking baseline dysfunction; leaves open whether blockade could mitigate human ventricular arrhythmias.
Connexin-43 (Cx43) is the most abundant protein forming gap junction channels (GJCs) in cardiac ventricles. In multiple cardiac pathologies, including hypertrophy and heart failure, Cx43 is found remodeled at the lateral side of the intercalated discs of ventricular cardiomyocytes. Remodeling of Cx43 has been long linked to spontaneous ventricular arrhythmia, yet the mechanisms by which arrhythmias develop are still debated. Using a model of a dystrophic cardiomyopathy, we previously showed that remodeled Cx43 function as aberrant hemichannels (non-forming GJCs) that alter cardiomyocyte excitability and, consequently, promote arrhythmias. Here, we aim to evaluate if opening of remodeled Cx43 can serve as a general mechanism to alter cardiac excitability independent of cellular dysfunction associated with a particular cardiomyopathy. To address this issue, we used a genetically modified Cx43 knock-in mouse (S3A) that promotes cardiac remodeling of Cx43 protein without apparent cardiac dysfunction. Importantly, when S3A mice were subjected to cardiac stress using the β-adrenergic agonist isoproterenol (Iso), they displayed acute and severe arrhythmias, which were not observed in WT mice. Pre-treatment of S3A mice with the Cx43 hemichannel blocker, Gap19, prevented Iso-induced abnormal electrocardiographic behavior. At the cellular level, when compared with WT, Iso-treated S3A cardiomyocytes showed increased membrane permeability and greater plasma membrane depolarization, which subsequently leads to triggered activity. These cellular dysfunctions were also prevented by Cx43 hemichannel blockers. Our results support the notion that opening of remodeled Cx43 hemichannels, regardless of the type of cardiomyopathy, is sufficient to mediate cardiac stress-induced arrhythmogenicity.
No takes yet. Share an insight, caveat, or question.
Lillo et al. (2022) studied Arrhythmias. Gap19 (Cx43 hemichannel blocker) vs. Vehicle was evaluated on Arrhythmogenic events within 24 hours post-isoproterenol injection. Pre-treatment with the Cx43 hemichannel blocker Gap19 prevented isoproterenol-induced abnormal electrocardiographic behavior and reduced arrhythmogenic events in S3A mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: